companydata.dkAktieselskabet af 16. februar 2024: Financial statements 2013
CVR: 33034911
Aktieselskabet af 16. februar 2024 (CVR 33034911) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 9,843,893 and a net result of DKK 1,538,179. Equity amounted to DKK 527,006. The solvency ratio was 7.3%.
- Gross Profit
- 9,843,893 kr.
- Profit/Loss
- 1,538,179 kr.
- Equity
- 527,006 kr.
- Total Assets
- 7,268,767 kr.
Find more companies like Aktieselskabet af 16. februar 2024
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of November 5, 2013, Wivi Hürwitz Larsen has joined the board of directors of Aktieselskabet af 16. februar 2024.
As of November 5, 2013, Birgit Lovise Uhrbrand Hansen has left the board of directors of Aktieselskabet af 16. februar 2024.
Aktieselskabet af 16. februar 2024 has published its interim report for the period July 1, 2012 – December 31, 2012.
As of April 12, 2013, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Aktieselskabet af 16. februar 2024.
As of January 1, 2013, Nina Stork has joined the board of directors of Aktieselskabet af 16. februar 2024.
As of January 1, 2013, Birgit Lovise Uhrbrand Hansen has joined the board of directors of Aktieselskabet af 16. februar 2024.
About Aktieselskabet af 16. februar 2024
Aktieselskabet af 16. februar 2024 was a Danish company of the type Aktieselskab based in København K, founded in 2010. The company was registered under the industry Speciallægers aktiviteter. The company was previously named TFP Stork Fertility A/S and STORK IVF KLINIK A/S. The company is owned by VivaNeo DK ApS. The company has 54 employees. In 2023, the company reported a gross profit of DKK 14,491,315 and a net result of DKK -13,702,784 compared with DKK -8,491,214 the year before. Equity amounted to DKK -27,031,558.